GnRH deficiency
Showing 1 - 25 of 3,872
Kallmann Syndrome, Idiopathic Hypogonadotropic Hypogonadism, GnRH Deficiency Trial in Boston (gonadotropin releasing hormone
Completed
- Kallmann Syndrome
- +2 more
- gonadotropin releasing hormone (GnRH)
-
Boston, MassachusettsMassachusetts General Hospital
Jun 29, 2022
Androgen Metabolism, Metabolic Disease and Skeletal Muscle
Not yet recruiting
- Hypogonadism, Male
- +10 more
-
Dublin 9, IrelandBeaumont Hospital
Mar 16, 2023
Genetic Causes of Kallmann Syndrome and Reproductive Disorders
Completed
- Hypogonadotropic Hypogonadism
- +4 more
-
Boston, MassachusettsMassachusetts General Hospital
Jun 29, 2022
Menopause, Estrogen Deficiency, Women Trial in Aurora (GnRH antagonist)
Recruiting
- Menopause
- +3 more
- GnRH antagonist
-
Aurora, ColoradoUniversity of Colorado Denver Anschutz Medical Campus
Jun 9, 2022
Hormonal Regulation of Puberty and Fertility
Recruiting
- Endocrine Disease
- +4 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 7, 2023
Psychological Outcomes in Isolated GnRH Deficiency
Terminated
- Hypogonadism
-
Bethesda, MarylandNational Institute of Child Health and Human Development (NICHD)
Jul 17, 2019
Inherited Reproductive Disorders
Recruiting
- Genetic Disorder
- +3 more
-
Bethesda, Maryland
- +1 more
Dec 29, 2022
Female Infertility Trial in Alexandria (gonadotropin releasing hormone-agonist, Progesterone)
Recruiting
- Female Infertility
- gonadotropin releasing hormone-agonist
- Progesterone
-
Alexandria, EgyptAlexandria University
Apr 5, 2022
Luteal Phase Deficiency, Luteal Phase Support, Idiopathic Hypogonadotropic Hypogonadism Trial in Shanghai (Additional hCG
Recruiting
- Luteal Phase Deficiency
- +2 more
- Additional hCG injection
- estrogen and dydrogesterone
-
Shanghai, Shanghai, China
- +1 more
Oct 5, 2022
Freeze All Strategy Versus Fresh Embryo Transfer After GnRH
Completed
- Ovarian Hyperstimulation Syndrome
- Pregnancy Related
- obstetric outcomes after fresh versus cryopreserved embryo transfer
- (no location specified)
May 11, 2022
Post COVID-19 Anosmia (Loss of Smell) Trial in Foshan, Kafr Ash Shaykh, Riyadh (Aerosolized 13 cis retinoic acid plus Vitamin D,
Not yet recruiting
- Post COVID-19 Anosmia (Loss of Smell)
- Aerosolized 13 cis retinoic acid plus Vitamin D
- +2 more
-
Foshan, Guangdong, China
- +2 more
Nov 9, 2021
Ovarian Stimulation, Human Chorionic Gonadotropin, Oocyte Donors Trial in Thessaloniki (Dual trigger (human chorionic
Recruiting
- Ovarian Stimulation
- +2 more
- Dual trigger (human chorionic gonadotropin plus GnRH-agonist)
- GnRH-agonist only trigger
-
Thessaloniki, GreeceEmbryolab Fertility Clinic
Nov 20, 2023
Hyperandrogenemia, Polycystic Ovary Syndrome (PCOS) Trial in Charlottesville (estrace, Progesterone)
Active, not recruiting
- Hyperandrogenemia
- Polycystic Ovary Syndrome (PCOS)
-
Charlottesville, VirginiaCenter for Research in Reproduction
Apr 27, 2021
Hormones Trial in Research Triangle Park (NEA, DEA)
Completed
- Hormones
- NEA
- DEA
-
Research Triangle Park, North CarolinaNIEHS Clinical Research Unit (CRU)
Aug 24, 2022
Some Puberty-related Hormones Among Children and Chronic Kidney
Not yet recruiting
- Evaluation of Some Puberty-related Hormones Among Children and Adolescents With Chronic Kidney Diseases
- serum kisspeptin levels
-
Sohag, EgyptSohag University Hospital
Apr 18, 2023
Fertility Trial in Barcelona (150µg CFA (Elonva®) at stimulation day (SD) 1 and 100µg CFA(Elonva®) at SD 5, 150µg CFA (Elonva®)
Not yet recruiting
- Fertility
- 150μg CFA (Elonva®) at stimulation day (SD) 1 and 100μg CFA(Elonva®) at SD 5
- 150μg CFA (Elonva®) at SD 1 following by rFSH (Puregon®) 200IU daily from SD 8 until the day of the trigger
-
Barcelona, SpainHospital Universitario Quiron Dexeus
Nov 10, 2023
Miscarriage, Recurrent Trial in Kuala Lumpur (GNRH Analoge, Duphaston, Letrozole)
Completed
- Miscarriage, Recurrent
- GNRH Analoge, Duphaston, Letrozole
-
Kuala Lumpur, MalaysiaUniversitiKMMC
Jun 24, 2022
Tibolone Add-back in Patients With Endometriosis and Fibroids
Not yet recruiting
- Endometriosis
- Fibroids
- Tibolone 2.5 Mg Oral Tablet
-
Montreal, Quebec, CanadaMcGill University Health Center
Nov 28, 2022
Infertility, Female Trial in Worldwide (FE 999049 + GnRH agonist (GONAPEPTYL), FE 999049 + GnRH antagonist (CETROTIDE))
Completed
- Infertility, Female
- FE 999049 + GnRH agonist (GONAPEPTYL)
- FE 999049 + GnRH antagonist (CETROTIDE)
-
Dobl, Austria
- +15 more
Sep 28, 2022
IVF, PCO Trial in Bani Suwayf (Dydrogesterone Tablets, Cetrorelix)
Not yet recruiting
- IVF
- PCO
- Dydrogesterone Tablets
- Cetrorelix
-
Banī Suwayf, Beni Suef, EgyptBeni-suef university Hospital
Jul 16, 2023
Infertility Trial in Giza (Double trigger, HCG trigger)
Not yet recruiting
- Infertility
- Double trigger
- HCG trigger
-
Giza, EgyptBedaya Hospital
Nov 23, 2023
Hypogonadism, Male, Infertility, Male, Testosterone Deficiency Trial (Natesto Nasal Product)
Not yet recruiting
- Hypogonadism, Male
- +2 more
- Natesto Nasal Product
- (no location specified)
Jan 4, 2022
IVF Trial in Bani Suwayf (Dydrogesterone, Cetrorelix acetate, Triptorelin)
Recruiting
- IVF
- Dydrogesterone
- +2 more
-
Banī Suwayf, Beni Suef, EgyptBeni-suef university Hospital
Aug 1, 2023
Hypogonadism, Hypogonadotropic, Obesity Trial in Houston (anastrozole (1 mg/day), Placebo)
Recruiting
- Hypogonadism, Hypogonadotropic
- Obesity
- anastrozole (1 mg/day)
- Placebo
-
Houston, TexasMichael E. DeBakey VAMC
Jan 19, 2022